These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 1569476
21. 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Flower MA, Zweit J, Hall AD, Burke D, Davies MM, Dworkin MJ, Young HE, Mundy J, Ott RJ, McCready VR, Carnochan P, Allen-Mersh TG. Eur J Nucl Med; 2001 Jan; 28(1):99-103. PubMed ID: 11202458 [Abstract] [Full Text] [Related]
22. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM. Matsumoto K, Fujibayashi Y, Yonekura Y, Wada K, Takemura Y, Konishi J, Yokoyama A. Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613 [Abstract] [Full Text] [Related]
23. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). Lewis JS, Herrero P, Sharp TL, Engelbach JA, Fujibayashi Y, Laforest R, Kovacs A, Gropler RJ, Welch MJ. J Nucl Med; 2002 Nov; 43(11):1557-69. PubMed ID: 12411560 [Abstract] [Full Text] [Related]
24. Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET. Young H, Carnochan P, Zweit J, Babich J, Cherry S, Ott R. J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):89-91. PubMed ID: 7632775 [Abstract] [Full Text] [Related]
27. Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia. Takahashi N, Fujibayashi Y, Yonekura Y, Welch MJ, Waki A, Tsuchida T, Sadato N, Sugimoto K, Nakano A, Lee JD, Itoh H. Ann Nucl Med; 2001 Jun; 15(3):293-6. PubMed ID: 11545205 [Abstract] [Full Text] [Related]
29. Effects of ischemia-reperfusion injury on myocardial single pass extraction and retention of Cu-PTSM in perfused rat hearts: comparison with 201T1 and 14C-iodoantipyrine. Wada K, Fujibayashi Y, Taniuchi H, Tajima N, Tamaki N, Konishi J, Yokoyama A. Nucl Med Biol; 1994 May; 21(4):613-7. PubMed ID: 9234318 [Abstract] [Full Text] [Related]
33. Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET). Taniuchi H, Fujibayashi Y, Okazawa H, Yonekura Y, Konishi J, Yokoyama A. Biol Pharm Bull; 1995 Aug; 18(8):1126-9. PubMed ID: 8535408 [Abstract] [Full Text] [Related]
37. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Adonai N, Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME, McCarthy T, McCarthy DW, Gambhir SS. Proc Natl Acad Sci U S A; 2002 Mar 05; 99(5):3030-5. PubMed ID: 11867752 [Abstract] [Full Text] [Related]
38. Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia. Taniuchi H, Fujibayashi Y, Yonekura Y, Konishi J, Yokoyama A. J Nucl Med; 1997 Jul 05; 38(7):1130-4. PubMed ID: 9225805 [Abstract] [Full Text] [Related]
39. Investigation of copper-PTSM as a PET tracer for tumor blood flow. Mathias CJ, Welch MJ, Perry DJ, McGuire AH, Zhu X, Connett JM, Green MA. Int J Rad Appl Instrum B; 1991 Jul 05; 18(7):807-11. PubMed ID: 1787092 [Abstract] [Full Text] [Related]
40. In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. Mathias CJ, Welch MJ, Green MA, Diril H, Meares CF, Gropler RJ, Bergmann SR. J Nucl Med; 1991 Mar 05; 32(3):475-80. PubMed ID: 2005455 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]